E-mail: secretary@virologycongress.com | USA : +1-646-828-7579, UK : +44-203-695-1242 | August 21-23, 2017, Barcelona, Spain  


AE Aboulata

Plant Path. Res. Inst., Egypt

Dr Aboul-Ata Elnady ABOUL-ATA, Professor Dr. of Plantvirology, who was born on Mar.22nd 1948 in Sharkia, Egypt, is the president of ArSV (Arab Society for Virology) in 2013 for 3 years. He was formerly Department Head of Plant Virus and Phytoplasma Research, Plant Pathology Research Institute at Agricultural Research Center, Giza, Egypt for 3 years (2003-2006), and Head of Molecular laboratoryat Plant Virus and Phytoplasma Res. from Sep. 2005 up to now. In 2007 he has been awarded committee membership of Egyptian Society of Advanced Material and NanoTechnology.He is being a committee-member of Egyptian Society of Virology(ESV) since initiation in 2001 up to now. He is the General Secretary for ESV since 2014 for 3-year period. He is beingmember of the Molecular Virology Group at the University of Kentucky, USA, American Phytopathological Society, The New York Academy of Sciences, American Society for Microbiology, Federation of British Plant Pathologists (FBPP) UK, Egyptian Society of Entomology, Egyptian Society of Plant Pathology, Egyptian Society of Applied Microbiology, African Virology Associan (AVA), South Africa, Who'sWho in the World, Record # World-18, 2001 GNNF 2852757104, USA. He is partner as ArSV president and keynote speaker for 3 successive international congress on virology i.e. International Congress on Virology organized by OMICS and ArSV, that will be held in Baltimore, USA during Nov. 20-22, 2013, MENA (Middle East and North Africa) organized by Science International and ArSV that will be held in Dubai during Jan. 21-23, 2014 and STDs organized by OMICS and ArSV that will be held in Sweden during 2014.

Tomáš Hanke

Kumamoto University, Japan.

Professor Tomas Hanke's research aims to develop a universal HIV-1 vaccine, which targets most global virus variants including escape mutants. He strives to maintain a balance between basic and translational research. He oversees a busy pre-clinical programme encompassing HIV-1 epitope discovery and dynamics using mass spectrometry and T-cell assays, studies on immunodominance, depth (number of variants) of epitope recognition and the importance of perfect vaccine-virus epitope matching for effective effector functions. He explores novel vaccine modalities and optimize their immunogenicity in heterelogous prime-boost regimens in mice and macaques. He co-ordinates a clinical programme assessing candidate HIV vaccines in humans in UK, Europe and Africa.

Valentina A. Divocha

Doctor of Medicine, Professor Odessa, Ukraine.

Divocha Valentinain 1967 shegraduated from I. I. Mechnikov OdessaState University, Faculty of Biology (Department of Virology). In 1973 continued herpostgraduate study ate OdessaInstitute of Virologyand Epidemiology (specialty virology).In 1974 she was awarded her candidate degree with the thesis"Interaction ofCoxsackie Bviruseswith sensitivecell culturesand theirantigenicrelationships." In 2009 she was awarded her doctoral degree with the thesis entitled"Biological basis antiproteinasetherapyof influenza". Under her leadershipperformed a doctoraland twomaster's theses. Scientificexperienceis 35 years.I have more than190 scientific publications,3monographs, textbook "Virology" (2012), 10 patents, 3 innovations. I am currently workingas the head ofthe Laboratory of ExperimentalandClinical Pathology for UkrainianResearch Instituteof Transport Medicine, is the supervisor ofthe nineresearch programsin virologyand biochemistry.

Girish J. Kotwal

UMass Medical School, Worcester, MA, USA

Girish J. Kotwal, Ph.D. has worked on a number of clinically important viruses like HIV, HCV, pox viruses, herpes viruses, etc at a number of institutions in Canada, USA and South Africa and has over 100 pubmed listed publications and over a dozen patents. He was a Visiting fellow and later a visiting associate at the National Institute of Health , Bethesda, MD, USA, a tenured Associate Professor at University of Louisville School of Medicine, Professor and Chair of Medical Virology at the University of Cape Town and is currently Adjunct Professor of Medicine at UMass Medical School.

Kathleen Laura Hefferon

Cornell University, New York.

Kathleen Hefferon received her PhD from the Department of Medical Biophysics, University of Toronto and continued her post-doctoral studies at Cornell University. Dr. Hefferon has worked on faculty at the Division of Nutritional Sciences at Cornell and has written two books on biopharmaceuticals in plants. She teaches and conducts research at both the University of Toronto and Cornell University. Kathleen has 4 patents, has edited 6 books, and has multiple research publications. Kathleen currently lives with her family near Ithaca NY.

Július Rajčáni

Alpha medical Pathology ltd, Martin, Slovakia Research Triangle Europe,Hungary

Dr. Rajčáni graduated at the Med. Faculty of Comenius University in Bratislava, 1960, the defended his thesis Pathogenesis of HSV-1 infection in mice“for PhD (CSc) in 1970, at the Institute of Virology, Bratislava. Doctor of sciences (Science doctor, ScD) obtained in 1985. Thesis: Pathogenesis of Virus Infections (monography published in Slovak, 1983, Publ. House SAS, Veda, Bratislava, 312 pages). Recent affiliations are research adviser at Alpha medical Laboratory Company, Pathology Department at Martin, Slovakia (for 10 hr weekly) and research adviser at RTE company (Research Triangle Europe, Western Hungary University, in town Mosonmagyaróvár, Hungary, near Bratislava), for 12 hr weekly.


Banner University Medical Center, Tucson,AZ,USA.

Dr. De received Bachelor of Science degree with honors in chemistry and Master of Science in biochemistry from Calcutta University, India. He worked for few years at a National Cancer Institute in India before coming to US for post- graduate education in 1975. After completion of Ph.D in biochemistry from University of Maryland in 1980, he underwent two postdoctoral trainings in basic cancer research under the supervisions of Dr. Leon Heppel, National Academy of Sciences, at Cornell University, Ithaca, NY and Dr. Stanley Cohen, Nobel laureate, Medicine 1986, at Vanderbilt University, Nashville, TN. Gradually, he became highly interested in Clinical Chemistry. In 1993, he took a fellowship in clinical chemistry and toxicology under the supervisions of both Dr. Amadeo Pesce and Dr. Bradley Copeland at University of Cincinnati Medical Center, Cincinnati, OH. Following completionhe joined University of Mississippi Medical Center in 1995 as the Associate Director of clinical chemistry and toxicology. In 2005, Dr. De was appointed the Director of clinical chemistry and toxicology in the department of Pathology, University of Arizona Health Sciences Center. He is a board certified clinical chemist from the American Board of Clinical Chemistry, a board certified toxicologist from the National Registry of Clinical Chemistry and a fellow of the National Academy of Clinical Biochemistry. Since 2010, Dr. De has been serving as a member of the board of directors in the American Board of Clinical Chemistry, Toxicology and Molecular Biology. Last year he is elected to be the chair of the nomination committee, American Board of Clinical Chemistry, Toxicology and Molecular Pathology. He has published more than 68 peer reviewed articles and meeting abstracts in basic and clinical sciences. He is a reviewer of both national and international journals and received recognitions as a Clinical Chemist from the American Association of Clinical Chemistry. In 2013 he was honored for the “Paul Finley Chemist Award” from University of Arizona Health Sciences Center. He is the co-principal investigator of a Center of Disease Control (CDC) sponsored project on HIV screening and diagnosis.

Virology Congress 2017 | by: Scientific Future Group